Related Experiment Videos
Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis
1CURE: Digestive Diseases Research Center, West Los Angeles VA Medical Center, 90073, USA.
Digestive Diseases and Sciences
|September 18, 1999
Summary
Brain corticotropin-releasing factor (CRF) plays a key role in stress responses, including delayed gastric emptying. Blocking CRF action may help treat conditions like cyclic vomiting syndrome (CVS).
Area of Science:
- Neuroscience
- Gastroenterology
- Endocrinology
Background:
- Corticotropin-releasing factor (CRF) and its receptors are crucial in the stress response.
- Brain CRF influences various physiological systems, including gastric function.
Purpose of the Study:
- To investigate the role of central CRF in mediating stress-induced delayed gastric emptying.
- To explore the potential of CRF antagonists in managing conditions like postoperative ileus and cyclic vomiting syndrome (CVS).
Main Methods:
- Administration of CRF into cerebrospinal fluid or periphery in various species.
- Utilizing specific CRF antagonists to block CRF action.
- Observing effects on gastric emptying and ileus in rat models.
- Analyzing the link between CVS symptoms and central CRF activation.
Main Results:
- CRF administration inhibits gastric emptying.
- Central CRF mediates stress-induced delayed gastric emptying in rats.
- CRF antagonists prevent postoperative gastric ileus.
- CVS symptoms correlate with central CRF activation, and therapies targeting CRF are effective.
Conclusions:
- Brain CRF is a key mediator of stress-induced gastrointestinal dysfunction.
- CRF antagonists show therapeutic potential for conditions like CVS and postoperative ileus.
- Further research into central CRF activation in CVS pathophysiology is warranted.